JSPR Jasper Therapeutics Inc

Price (delayed)

$0.5668

Market cap

$18.86M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.04

Enterprise value

$11.4M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 9

Jasper Therapeutics, Inc. is a biotechnology company focused on the development of novel curative therapies based on the biology of the hematopoietic stem cell. The company is advancing two potentially ...

Highlights
JSPR's debt has shrunk by 87% YoY and by 64% QoQ
The EPS has surged by 83% year-on-year and by 61% since the previous quarter
JSPR's equity has dropped by 94% year-on-year and by 58% since the previous quarter
JSPR's quick ratio is down by 49% year-on-year and by 39% since the previous quarter

Key stats

What are the main financial stats of JSPR

JSPR stock price

How has the Jasper Therapeutics stock price performed over time
Intraday
-9.01%
1 week
-2.43%
1 month
-20.84%
1 year
-76.38%
YTD
-69.03%
QTD
34.63%

Financial performance

How have Jasper Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$55.16M
Net income
-$31.77M
Gross margin
N/A
Net margin
N/A
Jasper Therapeutics's net income has surged by 65% YoY and by 43% QoQ
The operating income has increased by 41% year-on-year and by 24% since the previous quarter

Price vs fundamentals

How does JSPR's price correlate with its fundamentals

Growth

What is Jasper Therapeutics's growth rate over time

Valuation

What is Jasper Therapeutics stock price valuation
P/E
N/A
P/B
11.23
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 83% year-on-year and by 61% since the previous quarter
JSPR's equity has dropped by 94% year-on-year and by 58% since the previous quarter
The price to book (P/B) is 58% higher than the last 4 quarters average of 7.8

Efficiency

How efficient is Jasper Therapeutics business performance
The company's return on assets rose by 27% QoQ and by 22% YoY
The company's return on equity fell by 18% QoQ

Dividends

What is JSPR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for JSPR.

Financial health

How did Jasper Therapeutics financials performed over time
JSPR's total assets is 14% greater than its total liabilities
JSPR's total assets has dropped by 75% year-on-year and by 44% since the previous quarter
The company's total liabilities has shrunk by 55% YoY and by 42% QoQ
JSPR's debt is 81% lower than its equity
The debt to equity has surged by 111% year-on-year but it has declined by 14% since the previous quarter
JSPR's equity has dropped by 94% year-on-year and by 58% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.